KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) EPS (Basic) (2016 - 2025)

Gilead Sciences' EPS (Basic) history spans 17 years, with the latest figure at $1.76 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 23.94% year-over-year to $1.76; the TTM value through Dec 2025 reached $6.85, up 1751.35%, while the annual FY2025 figure was $6.84, 1700.0% up from the prior year.
  • EPS (Basic) reached $1.76 in Q4 2025 per GILD's latest filing, down from $2.46 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $2.46 in Q3 2025 to a low of -$3.34 in Q1 2024.
  • Average EPS (Basic) over 5 years is $1.02, with a median of $1.25 recorded in 2021.
  • Peak YoY movement for EPS (Basic): surged 3950.0% in 2023, then plummeted 512.35% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at $0.31 in 2021, then surged by 322.58% to $1.31 in 2022, then fell by 12.21% to $1.15 in 2023, then grew by 23.48% to $1.42 in 2024, then grew by 23.94% to $1.76 in 2025.
  • Per Business Quant, the three most recent readings for GILD's EPS (Basic) are $1.76 (Q4 2025), $2.46 (Q3 2025), and $1.57 (Q2 2025).